Skip to main content

Table 2 Intraoperative blood loss

From: Does the anatomical region predict blood loss or neurological deficits in embolized renal cancer spine metastases? A single-center experience with 31 patients

  Group Mean Std p value
dHB TSM 2.0 ±0.8485 p=0.3934
LSM 1.6 ±0.2268
TSM+ch 1.9 ±1.14 p=0.1429
LSM+ch 0.9 ±0.3464
TSM-ch + LSM-ch 1.831 ±1.167 p=0.5704
TSM+ch + LSM+ch 1.5667 ±1.045
Hb preoperatively TSM-ch 7.218 ±1.11 p=0.7517
TSM+ch 7.367 ±1.9
LSM-ch 7.209 ±1.429 p=0.5852
LSM+ch 6.60 ±1.179
TSM-ch + LSM-ch 7.214 ±1.249 p=0.5415
TSM+ch + LSM+ ch 7.111 ±1.676
Hb postoperatively TSM 5.345 ±0.7421 p=0.7862
TSMch 5.467 ±1.372
LSM 5.418 ±0.9411 p=0.5824
LSMch 5.7 ±0.9539
TSM+LSM 5.382 ±0.8279 p=0.4564
TSMch+LSMch 5.544 ±1.045
  1. Intraoperative blood loss was determined based on the preoperative and postoperative hemoglobin (Hb) levels. Presented as delta (d) Hb and the absolute Hb values in the whole patient collective (TSM, LSM) and in comparison, between the patient groups without (TSM-ch, LSM-ch) and with chemotherapy (TSM+ch, LSM+ch)